You Searched For "antiviral research" and got 18 results
Sort By:
2 mins read
SARS-CoV-2 proteins have been found hiding in blood of long COVID patients. Can this explain the persistent infection?
A Harvard study found that 43% of long COVID sufferers had these proteins, suggesting persistent in…
1 min read
Pioneering RNA vaccines could tackle all future virus mutations, eliminate need for booster doses
This method addresses the challenge of viral mutation by targeting thousands of sections of the vir…
2 mins read
Indian-origin researcher develops antiviral therapy that block Covid transmission
To our knowledge, this is the only single-dose antiviral that reduces not only symptoms and severit…
2 mins read
The ageing of nasal tissues may explain why older people are more affected by COVID-19: research
To comprehend how the coronavirus attacks our bodies, a study investigated the role of our noses, w…
4 mins read
The first-ever COVID-19 pill may be just weeks away. A handful of other pills, inhalers, and nasal sprays also show promise.
Easy-to-take coronavirus treatments could complement vaccines. These are the most promising ones to…
Aria Bendix,Andrew Dunn
4 mins read
The FDA has authorized pills to treat COVID-19, replenishing the tool kit of treatments against Omicron
The FDA on Thursday authorized Merck's antiviral pill, one day after authorizing Pfizer's pill.
Andrew Dunn,Allison DeAngelis
4 mins read
An FDA expert panel narrowly supports the first COVID-19 pill but suggests restrictions on its use driven by safety concerns
A COVID-19 pill could prevent infected people from getting seriously sick. But the FDA panel expres…
Andrew Dunn,Andrea Michelson
3 mins read
Researchers at Northwestern University are working on a self-sanitizing mask design to slow the spread of pandemics like COVID-19
In March, the National Science Foundation awarded a $200,000 Rapid Response Research grant to scien…
Don Reisinger,Don Reisinger
1 min read
Retail investors are dumping shares of COVID-19 vaccine makers and piling into antiviral pill maker Merck, data shows
Merck shares have jumped since the drug maker said molnupiravir cuts the risk of COVID hospitalizat…
Carla Mozée
6 mins read
A COVID-19 pill could soon fill a gap in our pandemic response that vaccines can’t overcome
Antivirals that can be taken orally are "one more piece of the larger puzzle of solving the COVID p…
Andrew Dunn
2 mins read
The Biden administration plans to invest $3.2 billion in COVID-19 antiviral drugs
The plan - called the Antiviral Program for Pandemics - will be funded through the American Rescue …
Natalie Musumeci
4 mins read
Forsythia is an herbal remedy that may have antibacterial and antiviral properties
Forsythia has been used in Traditional Chinese Medicine to treat various symptoms including nausea,…
Ashley Laderer
2 mins read
Gilead sold $873 million worth of its antiviral COVID-19 treatment even though data on its success remains mixed
Gilead posted its first numbers detailing how much money the pharmaceutical company has made throug…
Allana Akhtar
4 mins read
Remdesivir proved to be the first useful tool we have in treating COVID-19 patients. Now, the US government wants to find out more about how it could be supercharged with other drugs.
The National Institutes of Health announced a massive new study Friday to test 3 immune modulators …
Andrew Dunn
5 mins read
Trump got Regeneron's experimental antibody drug for his coronavirus symptoms. Here's what you need to know about the treatment.
President Donald Trump and first lady Melania Trump tested positive for the novel coronavirus on Fr…
Andrew Dunn,Lydia Ramsey Pfla…
1 min read
'Potential target for antiviral treatment for COVID-19 identified'
The researchers, including those from Cornell University in the US, compared the molecular sequenc…
PTI
10 mins read
The 10 most promising coronavirus treatments that could help curb the pandemic, even without a vaccine
Most have entered human trials, and a few have already seen positive data — but some candidates hav…
Aria Bendix,Andrew Dunn
3 mins read
From Arvind Fashions to Peter England, apparel makers are betting on anti-viral fabric but they might not necessarily fend off COVID-19
With the fear of the coronavirus pandemic still looming large, retailers and brands have been innov…